(Q35628264)

9 August 2017

Mononuclear cell subsets and coronary artery lesions in Kawasaki disease (English)

1 reference

9 August 2017

Furukawa S

1

1 reference

9 August 2017

Matsubara T

series ordinal

2

1 reference

9 August 2017

Yabuta K

series ordinal

3

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 June 1992

1 reference

Archives of Disease in Childhood

9 August 2017

1 reference

9 August 2017

67

1 reference

9 August 2017

6

1 reference

9 August 2017

706-708

1 reference

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

9 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1793803

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin

12 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1793803

Serum soluble CD4 and CD8 levels in Kawasaki disease

12 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1793803

Expression of on peripheral blood macrophages/monocytes in Kawasaki disease

12 July 2018

1 reference

12 December 2020

Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions

1 reference

12 December 2020

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

12 December 2020

Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.67.6.706

1 reference

9 August 2017

1 reference

9 August 2017

1 reference